Many tests and clinical staging tools are currently available, including digital rectal examination (DRE), prostate-specific antigen (PSA), prostate-specific antigen density (PSAD), sextant ...

A new IV bisphosphonate, zoledronic acid (Zometa), has demonstrated therapeutic benefits for patients with bone metastases from any solid tumor type, including prostate cancer, renal cell ...

ORION CORPORATION PRESS RELEASE 20 JUNE 2025 at 13.30 EEST CHMP recommends third indication for darolutamide for patients with advanced prostate cancer CHMP adopts positive opinion for the marketing ...

The analysis found that arolutamide (Nubeqa) plus androgen deprivation therapy (ADT) demonstrated positive impacts on health-related quality of life in patients with metastatic hormone-sensitive ...

Results showed that 308 patients (36.5%) underwent PSMA PET/CT before sRT. Those patients experienced significantly higher overall survival rates at 1, 2, and 5 years (100%, 99.5%, and 98.1%, ...

BASKING RIDGE, N.J. & RAHWAY, N.J.--(BUSINESS WIRE)-- The first patient has been dosed in the IDeate-Prostate01 phase 3 trial evaluating the efficacy and safety of investigational ifinatamab ...

AP IDeate-Prostate01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Pretreated Metastatic Castration-Resistant Prostate Cancer Business Wire Jun 18, 2025 Updated Jun 18, 2025 ...

A man diagnosed with incurable prostate cancer said the news felt like falling into a "black hole", as he urged others to check for signs of the disease. Danny Burkey, from Ossett, was diagnosed ...

Despite biopsy not being SOC for this patient population, approximately 16% of patients who were positive on 64 Cu-SAR-Bombesin PET/CT were biopsied in the SABRE study. All lesions assessed by ...

Background: Patients with Gleason score (GS) 9-10 prostate cancer (PCa) have a high risk of early biochemical recurrence (BCR). Salvage therapy options differ depending on the upfront management ...

Health & Medical Port Charlotte patient hails aquablation as a 'miracle' prostate solution Reporter: Amy Oshier Jun 13, 2025 Updated Jun 13, 2025 Loaded 0% - ...

The ProtecT trial was a large clinical study that compared surgery, radiation and active monitoring for prostate cancer. In the trial, 1,643 patients were assigned to one of three groups: surgery ...